Japan vs United States of America: New or unknown treatment history cases: Pulmonary, bacteriologically
Japan
6,346
in 2023
United States of America
6,535
in 2023
Japan rank
54th
United States of America rank
53rd
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Japan
- United States of America
How they compare
United States of America currently reports 6,535 against 6,346 in Japan, a difference of 189.
The two have swapped places 1 time across 11 shared years of data; in 2013 it was Japan ahead.
Japan ranks 54th and United States of America ranks 53rd of 197 countries.
Japan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Japan | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 11,029 | 5,881 | 5,148 | Japan |
| 2020s | 6,885 | 5,454 | 1,430 | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Japan or United States of America?
- United States of America, at 6,535 against 6,346 in Japan as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Japan and United States of America?
- 189, with United States of America ahead.
- How many years of comparable data are there for Japan and United States of America?
- 11 years are reported by both, from 2013 to 2023.
- How do Japan and United States of America rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Japan ranks 54th and United States of America ranks 53rd of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.